SoftBank made its second investment in the genomics tool developer as part of a round that enhanced its total funding to $185m.
US-based genomics technology developer 10x Genomics has received $50m in series D equity funding from investors including telecommunications and internet group SoftBank.
Private equity firm Meritech Capital Partners led the round, which also featured financial services firm Wells Fargo’s Strategic Capital unit, financial services group Fidelity and investment firm Paladin Capital. It was secured alongside $75m in debt financing from Silicon Valley Bank.
10x is combining novel microfluidics, chemistry and bioinformatics technology to develop tools to be used in genomics…
